Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by sah1on May 14, 2020 3:00pm
104 Views
Post# 31029121

RE:RE:RE:RE:RE:Read the MDA for Q1 2020

RE:RE:RE:RE:RE:Read the MDA for Q1 2020Ualcin,  I am just repeating words that I read in the MDA.  Covid is a curse on humanity but also small  busiesses including Lmnl. Galbraith said that the company had run the new quality control system successfully for 6 months. This suggests That Bla submission is ready and would be successful and approved in due course. But this can’t happen in the near term nor can the marketing deal . Looks like times are going to be very tough. 
<< Previous
Bullboard Posts
Next >>